Recent Announcement: Shenzhen Tobacco Monopoly Bureau's Responsibility List

Sep.19.2023
Recent Announcement: Shenzhen Tobacco Monopoly Bureau's Responsibility List
Recently, the Shenzhen Tobacco Monopoly Bureau released a list of rights and responsibilities. (Original Article: Shenzhen Tobacco Monopoly Bureau List of Rights and Responsibilities)

Recently, the Shenzhen Tobacco Monopoly Bureau released its list of powers and responsibilities. (Click to view the original article: List of Powers and Responsibilities of the Shenzhen Tobacco Monopoly Bureau)

 

The following is the full text:

 

Legal Basis (including national laws, regulations, rules, administrative normative documents, etc.):

 

Law of the People's Republic of China on Tobacco Monopoly" (Presidential Decree of the People's Republic of China No. 26, Revised on April 24, 2015)

 

The Implementation Regulations of the Tobacco Monopoly Law of the People's Republic of China (State Council Decree No. 750 of the People's Republic of China, revised on November 10, 2021)

 

The Administrative Coercion Law of the People's Republic of China (Presidential Decree No. 49 of the People's Republic of China, amended on June 30, 2011)

 

Administrative Reconsideration Law of the People's Republic of China" (Presidential Decree No. 16 of the People's Republic of China, revised on September 1, 2017)

 

Administrative Reconsideration Law Implementation Regulations of the People's Republic of China (State Council Decree No. 499, published on May 29, 2007)

 

6. "Administrative Penalties Procedures for Tobacco Monopoly" (Order No. 61 of the Ministry of Industry and Information Technology, January 21, 2010, amended on May 16, 2023).

 

Regulations on the Management of Tobacco Monopoly License (Ministry of Industry and Information Technology of the People's Republic of China Decree No. 36, revised on May 26, 2016)

 

Regulations on the Administration of Tobacco Monopoly Licenses" (Order No. 37 of the Ministry of Industry and Information Technology of the People's Republic of China, revised on May 26, 2016)

 

Regulations on the Management of E-Cigarettes" (Announcement No. 1 of 2022 by the State Tobacco Monopoly Administration)

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

84% of Britons Back Regulation of Nicotine Pouches, Survey Finds
84% of Britons Back Regulation of Nicotine Pouches, Survey Finds
A Northerner survey finds 84% of Britons support regulating nicotine pouches and 82% back a licensing scheme for vape sales, aligning with the Tobacco and Vapes Bill to improve consumer safety and youth protection.
Nov.06 by 2FIRSTS.ai
Thai Police Seize 30,000 Illegal Vapes Worth Over US$270,000
Thai Police Seize 30,000 Illegal Vapes Worth Over US$270,000
According to Thai police, officers seized 30,000 illegal vapes worth over THB 10 million (US$270,000) and arrested two suspects linked to online sales via LINE account “VST Nuan Chan.” Raids were conducted in Bangkok and Samut Prakan, uncovering a main warehouse and residence. Both suspects confessed and face charges under the Product Safety Act and Customs Law for illegal import and sale.
Oct.30 by 2FIRSTS.ai
Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.
Altria Q3 2025 Earnings Report: Net Revenue of $6.072 Billion and Launch of on!PLUS in the U.S.
Altria reported Q3 2025 net revenue of $6.072 billion, a 3.0% year-on-year decline. Adjusted EPS increased 3.6% to $1.45. The company expanded its share repurchase program to $2 billion and launched the on!PLUS nicotine pouch in Florida, North Carolina, and Texas.
Oct.31 by 2FIRSTS.ai
Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance
Scandinavian Tobacco Group Reports Q3 2025 Results and Narrows Full-Year Guidance
Scandinavian Tobacco Group (STG) reported net sales of DKK 2.4 billion for Q3 2025, in line with last year. EBITDA before special items reached DKK 519 million with a 22.0% margin. Handmade Cigars and Next Generation Products saw organic growth, while Machine-Rolled Cigars and Smoking Tobacco declined. The company narrowed its full-year guidance.
Nov.12 by 2FIRSTS.ai
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months
The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.
Oct.20 by 2FIRSTS.ai
Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%
Imperial Brands FY25 Results: NGP Net Revenue Up 13.7%, Americas Surges Nearly 70%
Imperial Brands reported FY25 NGP net revenue of £368 million, up 13.7% at constant currency. Growth in the Americas accelerated sharply, with NGP revenue up 69.8%, driven by the expansion of the modern oral brand Zone. Europe delivered 8.8% growth, supported by blu’s double-digit vapour share across key markets. Adjusted NGP operating losses narrowed to £76 million, putting the category closer to breakeven.
Nov.18 by 2FIRSTS.ai